Health and Fitness Health and Fitness
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012

PDL BioPharma to Announce Second Quarter 2012 Financial Results on August 2, 2012


//health-fitness.news-articles.net/content/2012/ .. ter-2012-financial-results-on-august-2-2012.html
Published in Health and Fitness on Thursday, July 19th 2012 at 4:17 GMT by Market Wire   Print publication without navigation


PDL BioPharma to Announce Second Quarter 2012 Financial Results on August... -- INCLINE VILLAGE, Nev., July 19, 2012 /PRNewswire/ --

PDL BioPharma to Announce Second Quarter 2012 Financial Results on August 2, 2012

[ ]
[ ]

INCLINE VILLAGE, Nev., July 19, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that the Company will release its second quarter financial results for the period ended June 30, 2012, on Thursday, August 2, 2012, after the market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results.  A slide presentation relating to the call will be available via the webcast link on the PDL website.

(Logo:  [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

Conference Call Details
To access the live conference call via phone, please dial (877) 677-9122 from the United States and Canada or (708) 290-1401 internationally. The conference ID is 12377244. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 9, 2012, and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally. The replay passcode is 12377244.

To access the live and subsequently archived webcast of the conference call, go to the Company's website at [ http://www.pdl.com ] and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing the value of its patent portfolio and related assets. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.pdl.com ]


Publication Contributing Sources